Midatech Pharma Plc Ret. on assets
What is the Ret. on assets of Midatech Pharma Plc?
The Ret. on assets of Midatech Pharma Plc is -121.07%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on LSE compared to Midatech Pharma Plc
What does Midatech Pharma Plc do?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Companies with ret. on assets similar to Midatech Pharma Plc
- Flying Service has Ret. on assets of -121.82%
- Faron Pharmaceuticals Oy has Ret. on assets of -121.73%
- Tetraphase Pharmaceuticals has Ret. on assets of -121.73%
- Micron Waste Technologies has Ret. on assets of -121.50%
- Baselode has Ret. on assets of -121.34%
- Esports Entertainment has Ret. on assets of -121.22%
- Midatech Pharma Plc has Ret. on assets of -121.07%
- Gour Medical SA has Ret. on assets of -120.98%
- AgeX Therapeutics Inc has Ret. on assets of -120.88%
- Origin Gold has Ret. on assets of -120.81%
- Acacia Coal has Ret. on assets of -120.73%
- BrainChip Ltd has Ret. on assets of -120.56%
- Safe & Green Corp has Ret. on assets of -120.18%